Brent Goldman Email and Phone Number
Founder And Gp
at
Lancelot Ventures
Brent Goldman's email is cagov@brentgoldman.com
and
Brent Goldman's phone number is +1626-616-6454
.
Brent Goldman's Contact Details
Email
cagov@brentgoldman.com
+9 emails
Phone
+1626-616-6454
+1 phones
Brent Goldman's Company Details
Company
Lancelot Ventures
Brent Goldman's Experience and Education
Work Experience
Brent Goldman
Angel Investor
2013-01 to Unknown
Lancelot Ventures
Founder And Gp
2013-01 to Unknown
Vice President, Head Of Engineering
2020-09 to Unknown
San Francisco, California, United States
Education
San Marino High School
2000 to 2004
Frequently Asked Questions about Brent Goldman
What company does Brent Goldman work for?
Brent Goldman works for Lancelot Ventures
What is Brent Goldman's role in his workplace?
Brent Goldman's role in his workplace is
Founder And Gp .
What is Brent Goldman's email address?
Brent Goldman's email address is cagov@brentgoldman.com
What is Brent Goldman's direct phone number?
Brent Goldman's direct phone number is +1626-616-6454
What schools did Brent Goldman attended?
Brent Goldman attended
Y Combinator,
Stanford University,
San Marino High School,
University Of Cambridge,
and
Caltech.
What are some of Brent Goldman's interests?
Brent Goldman has interests in
Personal Finance,
Marketplaces,
Mobile,
Personal Health,
Social Media,
Email,
All Markets,
Collaborative Consumption,
Local,
Commercial Real Estate,
Crowdfunding,
Facebook Applications,
Financial Services,
Developer Apis,
and
Bitcoin.
What are some of Brent Goldman's skills?
Brent Goldman has skills like
Software Engineering,
Python,
Javascript,
Php,
Mysql,
Git,
Mobile Applications,
Css,
Computer Science,
Software Development,
Web Development,
Distributed Systems,
Objective C,
C,
Web Applications,
Software Design,
Facebook Api,
Apache,
Linux,
Jquery,
and
Xml.
Who are Brent Goldman's peers at other companies?
Brent Goldman's peers at other companies are
Maiwada Muhammad,
Timothy R,
Alex Veilleux,
Zachary Ginsburg,
Maiwada Muhammad,
Tariq Muhtasib,
and
Sundeep A.
